A. Michelotti

Mismatch Repair Protein Loss as a Prognostic and Predictive Biomarker in Breast Cancers Regardless of Microsatellite Instability

Nicola Fusco, Gianluca Lopez, Chiara Corti et al. · JNCI Cancer Spectrum · 2018 · 80 citations · Full text

Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up

Marco Invernizzi, Chiara Corti, Gianluca Lopez et al. · BMC Cancer · 2018 · 42 citations · Full text

Breast Cancer Systemic Treatments and Upper Limb Lymphedema: A Risk-Assessment Platform Encompassing Tumor-Specific Pathological Features Reveals the Potential Role of Trastuzumab

Marco Invernizzi, A. Michelotti, Marianna Noale et al. · Journal of Clinical Medicine · 2019 · 36 citations · Full text

Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy

Francesco Cortiula, Lizza Hendriks, Robin Wijsman et al. · Radiotherapy and Oncology · 2023 · 21 citations · Full text

Role of luteinizing hormone-releasing hormone analog (LHRHa) triptorelin (T) in preserving ovarian function during chemotherapy for early breast cancer patients: Results of a multicenter phase III trial of Gruppo Italiano Mammella (GIM) group.

Lucia Del Mastro, Luca Boni, A. Michelotti et al. · Journal of Clinical Oncology · 2010 · 16 citations

Breast Oncology, Gynecology, Menopausal Hormone Therapy +23